lgg101

Leonard Gomella, MD

Contact Dr. Gomella

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. VAPC-1 Targeted 64Cu-TP3805 kit preparation and its evaluation
  2. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts
  3. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study
  4. The liquid biopsy for prostate cancer 25 years later
  5. Editorial Comment
  6. Prostate cancer statistics: Anything you want them to be
  7. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin
  8. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: The largest single-institution experience to date
  9. Decipher correlation patterns post prostatectomy: Initial experience from 2 342 prospective patients
  10. The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II)
  11. Clinical Influences in the Multidisciplinary Management of Small Renal Masses at a Tertiary Referral Center
  12. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  13. An Approach Using PSA Levels of 1.5‚ÄČng/mL as the Cutoff for Prostate Cancer Screening in Primary Care
  14. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer
  15. Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk
  16. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study
  17. Editorial Commentary
  18. VPAC1 targeted 64Cu-TP3805 positron emission tomography imaging of prostate cancer: Preliminary evaluation in man
  19. Prostate, breast and ovarian cancer genetic risk assessment: Connecting the dots
  20. TV drug commercials: Keeping physicians informed